INTELLIGENT BIO SOLUTIONS INC. (INBS) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, INTELLIGENT BIO SOLUTIONS INC.'s filing signal continuing negative.

Intelligent Bio Solutions Inc. is a medical technology company specializing in rapid, non-invasive testing and screening solutions, primarily through its Intelligent Fingerprinting Platform. This platform utilizes a portable reader and a disposable cartridge to analyze fingerprint sweat for the detection of drugs of abuse, including opiates, cannabis, and methamphetamines. The system is designed for safety-critical industries such as construction, transportation, and judicial organizations. The company manufactures its cartridges in Cambridge, England, and is actively pursuing regulatory approval in the United States, having completed a 510(k) submission for its opiate test system. Intelligent Bio Solutions operates globally, with a significant presence in the United Kingdom and expanding operations in the Asia Pacific and Americas regions.

Revenue is primarily driven by the sale of the Intelligent Fingerprinting System, which includes the portable readers, disposable cartridges, and accessories. Sales of these products to various industries constitute the main revenue stream.